Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (101-110 of 333) with videos related to

Pageof 34
Sort By:
Southern Medical Journal|June 1, 1975
Role of BCG immunotherapy in malignant diseaseE M Hersh, J U Gutterman, G M Mavligit, et al.
JAMA|April 22, 1992
Myelokathexis: normalization of neutrophil counts and morphology by GM-CSFM Wetzler, M Talpaz, M J Kellagher, et al.
Lancet (London, England)|December 14, 1974
Letter: Treatment of malignant melanomaJ U Gutterman, G M Mavligit, R C Reed, et al.
Blood|November 1, 1987
Expression of c-abl in Philadelphia-positive acute myelogenous leukemiaR Kurzrock, M Shtalrid, M Talpaz, et al.
Cancer Research|March 1, 1989
Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neckS A Maxwell, P G Sacks, J U Gutterman, et al.
National Cancer Institute Monograph|June 1, 1973
Cell-mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigensG M Mavligit, J U Gutterman, C M McBride, et al.
Seminars in Oncology|December 1, 1974
Immunochemotherapy of human cancerJ U Gutterman, G M Mavligit, R C Reed, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1974
Sialic acid on leukemia cells: relation to morphology and tumor immunityR C Reed, J U Gutterman, G M Mavlight, et al.
Medical and Pediatric Oncology|January 1, 1975
Active specific immunization in malignant melanomaF G Gercovich, J U Gutterman, G M Mavligit, et al.
Leukemia|August 1, 1987
Proto-oncogene expression in human normal bone marrowM J Evinger-Hodges, K A Dicke, J U Gutterman, et al.
Pageof 34

Showing results (101-110 of 333) with videos related to

Sort By:
Pageof 34
Southern Medical Journal|June 1, 1975
Role of BCG immunotherapy in malignant diseaseE M Hersh, J U Gutterman, G M Mavligit, et al.
JAMA|April 22, 1992
Myelokathexis: normalization of neutrophil counts and morphology by GM-CSFM Wetzler, M Talpaz, M J Kellagher, et al.
Lancet (London, England)|December 14, 1974
Letter: Treatment of malignant melanomaJ U Gutterman, G M Mavligit, R C Reed, et al.
Blood|November 1, 1987
Expression of c-abl in Philadelphia-positive acute myelogenous leukemiaR Kurzrock, M Shtalrid, M Talpaz, et al.
Cancer Research|March 1, 1989
Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neckS A Maxwell, P G Sacks, J U Gutterman, et al.
National Cancer Institute Monograph|June 1, 1973
Cell-mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigensG M Mavligit, J U Gutterman, C M McBride, et al.
Seminars in Oncology|December 1, 1974
Immunochemotherapy of human cancerJ U Gutterman, G M Mavligit, R C Reed, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1974
Sialic acid on leukemia cells: relation to morphology and tumor immunityR C Reed, J U Gutterman, G M Mavlight, et al.
Medical and Pediatric Oncology|January 1, 1975
Active specific immunization in malignant melanomaF G Gercovich, J U Gutterman, G M Mavligit, et al.
Leukemia|August 1, 1987
Proto-oncogene expression in human normal bone marrowM J Evinger-Hodges, K A Dicke, J U Gutterman, et al.
Pageof 34